Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
Clinical trial NCT02889900 · COMPLETED
Trial details
- NCT number
- NCT02889900
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-17
- Primary completion
- 2019-08-27
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.